![]() ![]() Together, they create the i-STAT System a point-of-care-testing platform that provides healthcare professionals with. Lightweight, portable and easy to use, the i-STAT 1 blood analyzer operates with the advanced technology of i-STAT test cartridges. In 2002 cash flow from Abbott prepayment. A handheld blood analyzer that delivers lab-quality, diagnostic results in minutes. ![]() On increasing cartridge usagenot analyzer sales volume Schedule disruptions in ambulatory surgery Each i-STAT CeliteACT cartridge provides a sample collection chamber, sensors to detect the coagulation endpoint, and dry reagents necessary to initiate and allow coagulation. Productivity and efficiency of clinical staffĮrror sources and lower costs Immediate i-STAT will capture a portion of this market.Ĭustomer's costs are reduced and converted from fixed to variable while i-STAT generates a greater product revenue and profit per test.Īchieve sizeable dollar savings in operating costs Increased 1 The test is virtually always performed at the point of care, primarily to monitor heparin anticoagulation therapy, especially at high heparin concentrations when the partial thromboplastin time cannot be used. Majority of the single glucose test market is controlled by the glucose meter companies. The activated clotting time (ACT) measures the time required for whole blood clotting after activation of the intrinsic pathway of the coagulation cascade. While both measure how quickly blood clots, they have distinct purposes: The PT test, also known as the PT/INR test, looks at the extrinsic pathway of coagulation (meaning coagulation that occurs after blood escapes a. The company in the future to be materially different from these statements, projections and materials.įor a complete list of risk factors with detailed descriptions, please refer to the Company's Form 10-K for the fiscal year ended Decemand to its Form 10-Q for theĭistribution Agreement≺bbott Laboratories 1999-2003 Prothrombin time (PT) and partial thromboplastin time (PTT) are tests used to evaluate coagulation, or the clotting of blood. Such statements, projections and materials involve known and unknown risks, uncertainties, and other factors which may cause the actual results, performance or achievements of Meaning of the Private Securities Litigation Reform Act of 1995. Activated clotting time (ACT) is a point-of-care coagulation test designed to monitor heparin therapy in the clinical situations in which intensive anticoagulation is required. Laboratory anti-Xa assay was used as the criterion standard for heparin measurement. If blood must be drawn from an indwelling line, possible heparin contamination and specimen dilution should be considered. Methods: We performed parallel testing of the ACCRIVA Hemochron Signature Elite ACT+ and Hemochron Response analyzer, iSTAT platform, and 2 Hepcon Hemostasis Management System (HMS) Plus analyzers for monitoring intraoperative heparin treatment. QuickLinks - Click here to rapidly navigate through this documentĬertain statements and materials in this presentation may relate to future events, projections and expectations and as such constitute 'forward-looking statements,' within the sample for coagulation testing.5 Indwelling line Fluid drip through the line must be discontinued. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |